Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

9.18
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
7.12
Today|||52-Week Range
11.63
+7.12%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line2.0M1.1M-2.5M-5.7M
 
 
 
 
 
Depreciation4.4M5.6M7.1M23.2M
 
 
 
 
 
Total Other Cash Flow3.7M3.2M3.7M25.4M
 
 
 
 
 
Funds From Operations10.1M10.0M8.3M42.8M
 
 
 
 
 
Funds From/For Other Operating Expenses7.9M517.0K1.9M21.4M
 
 
 
 
 
Net Cash Flow - Operating Activities2.2M9.5M6.4M21.5M
 
 
 
 
 
 
InvestingCapital Expenditures-2.0M-3.8M-2.2M-7.5M
 
 
 
 
 
Fixed Asset Disposal------1.0M
 
 
Net Assets From Acquisitions 0.00-5.8M-72.9M0.00
 
 
 
Net Cash Flow Investing-2.0M-9.6M-75.2M-6.5M
 
 
 
 
 
 
FinancingShort Term Borrowings-4.2M-4.3M10.0M12.9M
 
 
 
 
 
Long Term Borrowings0.000.0051.7M72.8M
 
 
 
Long Term Debt Reduction-2.6M-3.6M-4.1M-115.3M
 
 
 
 
 
Net Proceeds Stock Sale9.5M36.9M935.0K3.8M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing2.8M29.0M58.5M-25.9M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.00------
 
Net Change In Cash3.0M28.9M-10.3M-10.9M